동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)

  • 제28권1호
  • /
  • Pages.22-28
  • /
  • 2014
  • /
  • 1738-7698(pISSN)
  • /
  • 2288-2529(eISSN)
대한동의생리학회·한의병리학회 ( The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine)
권호 표지

유방암세포에서 괴화 에탄올 추출물의 NF-${\kappa}B$ 의존적인 MMP-9 발현의 조절 규명을 위한 연구

Effects of Flos Sophorae Ethanol Extract on NF-${\kappa}B$ Dependent MMP-9 Expression in Human Breast Cancer Cell

  • 김정미 (원광대학교 대사질환 연구센터) ;
  • 이영래 (원광대학교 대사질환 연구센터) ;
  • 황진기 (원광대학교 대사질환 연구센터) ;
  • 김미성 (원광대학교 대사질환 연구센터) ;
  • 김하림 (원광대학교 대사질환 연구센터) ;
  • 박연주 (원광대학교 대사질환 연구센터) ;
  • 유용욱 (원광대학교 치과대학 생화학교실, 생체재료.매식 연구소) ;
  • 김성철 (원광대학교 한의과대학 한방생리학교실) ;
  • 류도곤 (원광대학교 한의과대학 한방생리학교실) ;
  • 권강범 (원광대학교 한의과대학 한방생리학교실)
  • Kim, Jeong Mi (Center for Metabolic Function Regulation, Wonkwang University School of Medicine) ;
  • Lee, Young Rae (Center for Metabolic Function Regulation, Wonkwang University School of Medicine) ;
  • Hwang, Jin Ki (Center for Metabolic Function Regulation, Wonkwang University School of Medicine) ;
  • Kim, Mi Seong (Center for Metabolic Function Regulation, Wonkwang University School of Medicine) ;
  • Kim, Ha Rim (Center for Metabolic Function Regulation, Wonkwang University School of Medicine) ;
  • Park, Yeon Ju (Center for Metabolic Function Regulation, Wonkwang University School of Medicine) ;
  • You, Yong Ouk (Department of Oral Biochemistry, and Institute of Biomaterials.Implant, School of Dentistry, Wonkwang University) ;
  • Kim, Seong Cheol (Department of Korean Physiology, School of Korean Medicine, Wonkwang University) ;
  • Ryu, Do Gon (Department of Korean Physiology, School of Korean Medicine, Wonkwang University) ;
  • Kwon, Kang Beom (Department of Korean Physiology, School of Korean Medicine, Wonkwang University)
  • 투고 : 2013.12.11
  • 심사 : 2014.02.11
  • 발행 : 2014.02.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Flos Sophorae, the dried flower bud of Sophora japonica L, possesses anti-inflammatory properties, prevents and treats blood capillary and hypertension diseases and can also be used as a hemostat. However, the effect of Flos Sophorae on breast cancer invasion is unknown. Matrix metalloproteinase-9 (MMP-9), which degrades the extracellular matrix, is a major component in cancer cell invasion. In this study, we investigated the inhibitory effect of Flos Sophorae extract (FSE) on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced Matrix metalloproteinase-9 (MMP-9) expression and cell invasion, as well as the molecular mechanisms involved in Michigan Cancer Foundation-7 (MCF-7) cells. FSE inhibited the TPA-induced transcriptional activation of nuclear factor-kappa B (NF-${\kappa}B$). These results indicate that FSE-mediated inhibition of TPA-induced MMP-9 expression and cell invasion involves the suppression of NF-${\kappa}B$ pathway in MCF-7 cells. Thus, FSE may have therapeutic potential for controlling breast cancer invasiveness.

키워드

참고문헌

  1. 신민교. 임상본초학, 서울, 영림사, p 489, 2002.
  2. Kite, G.C., Veitch, N.C., Boalch, M.E., Lewis, G.P., Leon, C.J., Simmonds, M.S. Flavonol tetraglycosides from fruits of Styphnolobium japonicum (Leguminosae) and the authentication of Fructus Sophorae and Flos Sophorae. Phytochemistry 70(6):785-794, 2009. https://doi.org/10.1016/j.phytochem.2009.04.003
  3. Kim, J.M., Yun Choi, H.S. Anti-platelet effects of flavonoids and flavonoid-glycosides from Sophora japonica. Arch Pharm Res. 31(7):886-890, 2008. https://doi.org/10.1007/s12272-001-1242-1
  4. Tang, Y.P., Zhu, H.X., Duan, J.A. Two new isoflavone triglycosides from the small branches of Sophora japonica a. J Asian Nat Prod Res. 10(1-2):65-70, 2008. https://doi.org/10.1080/10286020701273858
  5. Tang, Y., Yang, R., Duan, J.A., Shang, E., Su, S., Zhu, M.,Qian, D. Isoflavone tetraglycosides from Sophora japonica Leaves.J Nat Prod. 71(3):448-450, 2008. https://doi.org/10.1021/np070396t
  6. Jung, C.H., Zhou, S., Ding, G.X., Kim, J.H., Hong, M.H., Shin, Y.C., Kim, G.J., Ko, S.G. Antihyperglycemic activity of herb extracts on streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem. 70(10):2556-2559, 2006. https://doi.org/10.1271/bbb.60238
  7. Kim, B.H., Chung, E.Y., Min, B.K., Lee, S.H., Kim, M.K.,Min, K.R., Kim, Y. Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity. Planta Med. 69(5):474-476, 2003. https://doi.org/10.1055/s-2003-39712
  8. National Cancer Information Center. National Cancer Statistics 2008. Available at: http://www.cancer.go.kr [accessed on 15 December 2010].
  9. Korean Breast Cancer Society Policy Committee. Breast Cancer Facts & Figures 2006-2008. Seoul, Korean Breast Cancer Society, 2008.
  10. 송바다, 김순례, 김성훈, 신용철, 고성균. Butein에 의한 MCF-7 유방암 세포의 세포사별에 의한 항암효과. 동의생리병리학회지 24: 385-389, 2010.
  11. Stetler-Stevenson, W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Metast Rev 9: 289-303, 1990. https://doi.org/10.1007/BF00049520
  12. Davies, B., Miles, D.W., Happerfield, L.C., Naylor, M.S., Bobrow, L.G., Rubens, R.D., et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993. https://doi.org/10.1038/bjc.1993.207
  13. Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D.L., Quigley, J.P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274: 13066-13076, 1999. https://doi.org/10.1074/jbc.274.19.13066
  14. Iwata, H., Kobayashi, S., Iwase, H., Masaoka, A., Fujimoto, N., Okada, Y. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res 87: 602-611, 1996. https://doi.org/10.1111/j.1349-7006.1996.tb00266.x
  15. Liotta, L.A., Steeg, P.S., Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991. https://doi.org/10.1016/0092-8674(91)90642-C
  16. Lee, K.S., Shin, M.K. Theen cyclopedia of oriental herbal medicine. Jungdam, Seoul, Korea. pp 381-383, 1997.
  17. Branen, A.L. Toxicology and biochemistry of butylated hydroxy anisol and butylated hydroxytoluene. JAmOilChemSoc 52: 59-63, 1975.
  18. Edwards, B.K., Brown, M.L., Winga P.A., Howe, H.L.,Ward, E., Ries, L.A., Schrag, D., Jamison, P.M., Jemal, A., Wu, X.C., Friedrnan, C., Harlan, L., Warren, J., Anderson, R.N., Pickle, L.W. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 97(19):1407-1427, 2005. https://doi.org/10.1093/jnci/dji289
  19. Park, S., Bae, J., Nam, B.H., Yoo, K.Y. Aetiology of cancer in asia. Asian Pac. J. Cancer. Prev. 9(3):371-380, 2008.
  20. Block, K.I., GyllenhaaI, C., Tripathy, D., Freels, S., Mead, M.N., Block, P.B., Steinrnann, W.C., Newman, R.A., Shoham, J. Survival impact of integrative cancer care in advanced metastatic breast canccr. Breast J. 15(4):357-366, 2009. https://doi.org/10.1111/j.1524-4741.2009.00739.x
  21. Gupta, G.P., Minn, A.J., Kang, Y., Siegel, P.M., Serganova, I., Cordon-Cardo, C., Olshen, A.B., Gerald, W.L., Massague, J. Identifying site-specific metastasis genes and functions. Cold Spring Harb. Syrnp. Quant. BioI. 70: 149-158, 2005. https://doi.org/10.1101/sqb.2005.70.018
  22. Cavallaro, U., Christofori, G. Cell adhesion in tumor invasion and metastasis: Loss of the glue is not enough Biochim. Biophys. Acta. 1552(1):39-45, 2001.
  23. 문구, 정병학, 김병주, 암 동성의 결합치료. 원광대학교 출판국. 1: 118-119, 1999.
  24. Woessner, J.F., Nagase, H. MMP and TIMPs. Newyork, Oxford Univ Press, 1: 253-256, 2000.
  25. Inomara, S., Matsunaga, Y., Amano, S., Nishiyama, T. Possible involvement of gelatinases in basal membrane damage and Wrinkle formation in chronicall UVB-exposed hairless mouse. J.Inv. Derm. pp 120-134, 2003.
  26. Rha, S.Y., Kim, S.J., Chung, H.C., Kim, J.H., Roh, J.K., Lee, K.S., Kim, B.S. Expression of Matrix-metalloproteinase-9 (MMP-9) in breast cancer. J. Kor. Cancer 28(2):247-252, 1996.
  27. Schwartz, S.A., Hernandez, S.A., Mark, E.B. The role of NF-kappaB/ IkappaB IkappaB proteins in cancer: implications for novel treatment strategies. Surg. Oncol. 8(3):143-153, 1999. https://doi.org/10.1016/S0960-7404(00)00012-8
  28. Oya, M., Ohtsubo, M., Takayanagi, A., Tachibana, M., Shimizu, N., Murai, M. Constituitive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene 20(29):3888-3896, 2001. https://doi.org/10.1038/sj.onc.1204525
  29. Figueroa, Y.G., Chan, A.K., Ibrahim, R., Tang, Y., Burow, M.E., Alam, J., Scandurro, A.B., Beckman, B.S. NF-kappaB plays a key role in hypoxia-inducible factor-1 regulated erythropoietin gene expression. Exp. Hematol. 30(12):1419-1427, 2002. https://doi.org/10.1016/S0301-472X(02)00934-7
  30. eyaert, R., Heyninck, K., Van Huffel, S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappaB-dependent gene expression and apoptosis. Biochem. Pharmacol. 60(8):1143-1151, 2000. https://doi.org/10.1016/S0006-2952(00)00404-4